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Cellular calcium uptake in the action of prostaglandins on renal
water excretion. The role of cellular calcium uptake in the anti-
diuretic response to vasopressin was studied in anesthetized
dogs undergoing water diuresis. In prostaglandin (PG) intact ani-
mals, an intrarenal infusion of verapamil caused only a modest
blunting of the response to antidiuretic hormone (ADH), because
the urinary osmolality (U0) achieved in the contralateral con-
trol kidney was 338 40 mOsmlkg H20 but was only 270 23
mOsm/kg H20 in the verapamil-infused kidney. The possibility
was then studied that PG inhibit the action of ADH by impairing
cellular calcium uptake. If so, verapamil would be expected to
abolish the effect of PG inhibition to enhance the action of ADH.
In eight PG-inhibited dogs, the control kidney's Uosm increased
to a mean of 650 103 mOsmlkg H20 but only to 280 22
mOsm/kg H20 in the infused side. Thus, verapamil abolished the
effect of PG inhibition to enhance the action of ADH. Likewise,
in five dogs a second chemically dissimilar inhibitor of calcium
transport, proadifen, also abolished the effect of PG inhibitors as
Uosm rose to 590 78 mOsmlkg H20 in the control kidney but
only to 278 11 mOsm/kg H20 in the proadifen-infused kidney.
Neither prior vasodilatation nor an increased solute excretion
with mannitol of a degree observed with verapamil mimicked the
effect of the calcium uptake blockers to inhibit the action of
ADH. The present in vivo studies therefore demonstrate that the
effect of PG inhibitors to enhance the hydroosmotic effect of
vasopressin involve cellular calcium transport.
La captation cellulaire de calcium dans l'action des prostaglan-
dines sur l'excrétion rénale d'eau. Le role de la captation cellu-
lalre de potassium sur Ia rCponse antidiuretique a la vasopressine
a etC étudiée chez les chiens anesthésiCs et soumis a une diurèse
aqueuse. Une perfusion intrarénale de vérapamil determine une
attenuation discrete de la réponse a d'hormone antidiurCtique
(ADH) puisque l'osmolalitC urinaire (U0,,,J obtenue dans le rein
controlatCral est de 338 40 mOsmIkg H20 mais seulement de
270 23 mOsm/kg H20 (P < 0,05) du cOté perfuse avec du ye-
rapamil. La possibilité que les prostaglandines (PG) inhibent
l'action de l'ADH en empCchant la captation cellulaire du cal-
cium a été étudiée. Si cela était le cas, on devrait s'attendre a ce
que le vérapamil abolisse l'effet de l'inhibition de PG qui aug-
mente l'action de l'ADH. Chez huit chiens dont PG était inhibé
Uom des reins contrôles a augmentC jusqu'à une valeur de 650
103 mOsni/kg H50, mais seulement a 280 22 mOsmlkg H20
du côté perfuse. Ainsi le vérapamil about l'effet de l'inhibition
de PG. De Ia méme facon, chez cinq chiens, un autre inhibiteur
du transport du calcium chimiquement different, le proadifen
(0,375 mg/kg/mm), about aussi l'effet des inhibiteurs de PG
puisque Uo,m augmente a 590 78 mOsmlkg H20 dans les reins
contrOles, mais seulement a 278 11 mOsm/kg H20 dans les
reins perfusés avec le proadifen. Ni Ia vasodilatation préalable,
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ni l'augmentation de l'excrétion de substances dissoutes par le
mannitol a un niveau comparable a celui observe avec le vCrapa-
mil ne reproduisent l'effet des inhibiteurs de la captation de cal-
cium. Les rCsultats obtenus in vivo démontrent donc que l'effet
des inhibiteurs de PG, l'augmentation de l'effet hydroosmotique
de Ia vasopressine, implique le transport cellulaire du calcium.
It has become increasingly evident that the ability
of vasopressin to augment the water permeability of
various epithelial surfaces can be modified by a
number of physiologic and pharmacologic factors
[1, 2]. Among these, the role of calcium has been
the subject of considerable investigation. It has thus
been amply recognized that both man [3] and exper-
imental animals [4] with chronic elevations in serum
calcium exhibit an impairment in maximal urinary
concentration. Likewise, acute elevations of serum
calcium also diminish the hydroosmotic effect of ex-
ogenous vasopressin [5].
More recently, attention has been directed to the
possibility that alterations in intracellular calcium
concentration could also play a critical role in the
action of vasopressin. The studies that support such
a view, however, have been performed exclusively
in vitro. Moreover, the results have not been entire-
ly consistent. For example, calcium ionophores
have been reported to both inhibit [6] and to en-
hance [7] the in vitro hydroosmotic effect of vaso-
pressin. The latter observation is more compatible
with the preliminary results of Humes et al [8] who
found that verapamil, a blocker of cellular calcium
transport, inhibits the hydroosmotic action of vaso-
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pressin on the toad bladder. In addition, the possi-
bility that the effect of pro staglandins (PG) to antag-
onize the action of vasopressin [9-Il] could also in-
volve cellular calcium transport has been suggested
in a preliminary in vitro study [12]. This possibility,
however, has not been examined in vivo. The pres-
ent experiments were therefore designed to assess
in vivo whether inhibition of cellular calcium trans-
port alters the renal response to vasopressin in both
PG-replete and -depleted dogs. The results demon-
strate that the hydroosmotic action of vasopressin
in vivo is partially attenuated by blockade of cellu-
lar calcium uptake. Even more pronounced, the ef-
fect of inhibition of PG synthesis to potentiate the in
vivo action of the vasopressin was totally abolished
by inhibition of cellular calcium uptake. Thus, not
only is cellular calcium uptake involved in the in
vivo hydroosmotic effect of vasopressin, but PG ap-
pears to antagonize the in vivo action of vasopres-
sin primarily by blocking cellular calcium transport.
Methods
Studies were performed in 30 mongrel dogs
weighing between 15 and 30 kg. Food was withheld
for 18 hours, and water was allowed ad lib. All ani-
mals were anesthetized with pentobarbital (30 ml!
kg), intubated, and ventilated with a Harvard res-
pirator (Harvard Apparatus Co., Inc., Mihis, Mas-
sachusetts). Light anesthesia was maintained
throughout by administration of supplemental pen-
tobarbital. Polyethylene catheters were placed in
both ureters and renal veins through bilateral flank
infusions by a retroperitoneal approach. Systemic
pressure was continuously monitored by a brachial
artery catheter connected to a Statham transducer
(Statham Instruments Inc., Oxnard, California). In
animals whose renal perfusion pressure was de-
creased prior to the experiment, a Blalock vascular
clamp was placed around the aorta above the renal
arteries. In these animals, a femoral artery catheter
was also placed so as to monitor pressure below the
clamp, and 60 mm before the experiment the renal
perfusion pressure was decreased to between 100
and 110 mm Hg. In animals that received intrarenal
infusions, a 25-gauge needle was placed in the renal
artery. After completion of surgery, a solution of
0.9% sodium chloride containing sufficient inuhin
and para-aminohippurate (PAH) was infused (0.5
ml!min) into a foreleg vein to maintain plasma levels
of these substances at 15 to 20 and 1 to 3 mg!dl,
respectively. At the same time, all animals received
a solution of 2.5% glucose and water infused in the
same foreleg vein at a rate of 20 mI/mm for 60 mm.
After the administration of this water load, the in-
fusion rate was decreased to 2 to 4 mI/mm above
urine flow rate. One to two hours were allowed for
recovery from surgery. Only animals that achieved
a stable water diuresis (Uosm below 100 mOsm!kg
H20) were studied. The periods of urine collection
during the experiments were between 5 and 10 mm
in duration. Arterial and renal venous blood sam-
ples were obtained at the midpoint of alternate urine
collections. The following experiments were under-
taken.
Studies in dogs with intact prostaglandin syn the-
rizing ability (N = 7). These studies were designed
to determine whether inhibition of transmembrane
influx of extracellular calcium inhibits or alters the
antidiuretic response to vasopressin. To this end,
we used verapamil (a-iso propyl a[N-methyl N-
homoveratyl-y-aminopropyl]-3 ,4 dimethoxyphenyl-
acetonitrite hydrochloride Knoll Pharmaceutical
Co., Whippany, New Jersey). The primary action
of this drug involves the inhibition of slow inward
calcium current [13, 14], an effect that is demon-
strable by calcium 45 uptake studies in bladder epi-
thelial cells [8].
Because in these preliminary studies the i.v. in-
fusion of verapamil was noted to cause a marked
decrease in systemic pressure, an intrarenal dose of
the drug was sought. An intrarenal infusion of 0.005
mg/kg/mm produced unilateral without systemic ef-
fects as evidenced by a failure to alter systemic
pressure and a lack of natriuresis in the uninfused
contralateral kidney when compared with the ipsi-
lateral-infused kidney [15]. After a stable water di-
uresis was established and control collections ob-
tained, intrarenal verapamil was started. Following
these clearance measurements, 100 mU of vaso-
pressin (Aqueous Pitressin, Parke, Davis and Co.,
Detroit, Michigan) was given i.v., and experimental
measurements were begun 10 mm later. When the
effect of vasopressin had dissipated, postcontrol
collections were obtained. This protocol allowed
for the comparison of the antidiuretic response to
vasopressin in the verapamil-infused kidney versus
the contralateral control kidney.
Studies in dogs whose prostaglandin synthesis is
inhibited. These experiments were designed to de-
termine whether the effect of PG to inhibit the ac-
tion of vasopressin involves the transcellular influx
of extracellular calcium. If so, agents that block
such a pathway would be expected to abolish the
effect of PG inhibitors to enhance the action of
vasopressin. The following protocols were under-
taken.
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(a) Intrarenal infusion of verapamil in PG-inhib-
ited dogs (N = 13). The experimental protocol for 8
of these animals was the same as the one described
above, except that the animals were pretreated with
indomethacin (10 mg/kg), a dose that is known to
inhibit PG synthesis in the anesthetized dog [16]. To
ascertain that PG inhibition was achieved, we mea-
sured the urinary PG excretion in 7 of these dogs
before indomethacin administration and during the
intrarenal infusion of verapamil. A urine modifica-
tion of the procedure of Dray, Charbonnel, and
Maclouf [17] was used. Because the infusion of ye-
rapamil caused an ipsilateral increase in renal blood
flow, an additional 5 animals were studied. The pro-
tocol was the same except that in these dogs a su-
prarenal aortic clamp was used to reduce renal per-
fusion pressure to between 100 and 110 mm Hg 60
mm before the experiment to vasodilate the kidneys
by autoregulation prior to verapamil administration.
(b) Intrarenal infusion of proadifen in PG-inhib-
ited dogs (N = 5). To ensure that the effects ob-
served with verapamil were indeed related to its ef-
fects on membrane calcium permeability, we used a
second chemically dissimilar drug that also blocks
cellular calcium uptake. Proadifen (SKF #525A) (2
diethylaminoethyl 2,2 diphenylvalerate hydro-
chloride) [18, 19] was obtained from Smith Kline &
French, Philadelphia, Pennsylvania. Because the
supply of this agent was limited, these five studies
were performed in dogs that were somewhat small-
er (15 to 20 kg). After preliminary studies, a dose of
0.375 mg/kg/mm intrarenally was found to produce
unilateral natriuresis and diuresis without systemic
hemodynamic changes [15]. The protocol was again
the same as described for the above intrarenal stud-
ies except that proadifen was given instead of vera-
pamil.
(c) Effect of increased solute excretion on the re-
sponse to vasopressin in PG-inhibited animals (N =
5). The administration of both verapamil and pro-
adifen caused a significant increase in solute clear-
ance. This effect was also seen in the 5 animals
whose renal perfusion pressure was reduced prior
to verapamil administration. Because the increase
in solute clearance could have modified the re-
sponse to vasopressin, solute excretion was in-
creased in 5 PG-inhibited dogs by the infusion of 5%
mannitol, 10 mI/kg, over 60 mm. The response of
these animals undergoing a solute diuresis to the
100 mU bolus of vasopressin was then tested.
Analytic measurements and the calculations used
for clearance measurements were performed as pre-
viously described [20]. Statistics were performed
using Scheffe's [21] analysis of variance between
experimental periods. Comparison between infused
and uninfused kidney in the same experimental pe-
riod were done with the Student's t test. A P value
of less than 0.05 was considered significant. All data
were expressed as the means SEM.
Results
Effect of verapamil on the renal response to vaso-
pressin in dogs with normal prostaglandin synthe-
tizing ability (Table 1). These experiments were un-
dertaken to determine whether the administration
of a blocker of cellular calcium uptake inhibits the
renal response to vasopressin. The intrarenal ad-
ministration of verapamil caused no detectable al-
terations in extracellular calcium concentration. In
view of the profound effect of the verapamil in-
fusion on systemic pressure, attempts were made to
find a dose that would produce unilateral renal ef-
fects of the drug. This was achieved with the ipsilat-
eral infusion of 0.005 mg/kg/mm of the drug. This
dose caused no significant changes in systemic pres-
sure, as mean arterial pressure was 143 10 before
and 138 7.5 mm Hg after verapamil. Likewise, as
is shown in Table 1, there were no alterations in the
function of the noninfused contralateral kidney. In
these PG-replete dogs, the increased renal blood
flow in the infused kidney did not achieve statistical
significance. The slight but significant increase in
basal Uosm reflects the increment in solute excretion
rather than presence of vasopressin in the circula-
tion, because the contralateral urine remained max-
imally dilute. The maximal urinary osmolality
achieved after the administration of 100 mU of
vasopressin was slightly but significantly greater in
the contralateral kidney (337 45 mOsm/kg H20)
than it was in the verapamil-treated kidney (270
23 mOsm/kg H20, P <0.05). A similar significant
difference (P < 0.05) was obtained when the in-
crement in Uosm for each kidney was analyzed.
Studies in dogs whose prostaglandin synthesis is
inhibited: (a) Effect of verapamil on the action of
vasopressin in PG-inhibited dogs (Table 2, Fig. 1).
These studies were undertaken to test the possi-
bility that PG antagonize the response to vasopres-
sin by inhibiting the transcellular movement of cal-
cium. If so, the potentiating effect of PG inhibition
on the hydroosmotic effect of vasopressin would be
diminished by agents that block this cellular path-
way. As shown in Fig. 1, the maximal Uosm
achieved after vasopressin administration was
markedly different in the kidney receiving vera-
pamil (infused kidney) than in the contralateral con-
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Table 1. Effect of intrarenal verapamil on renal hemodynamics and solute and water excretion in prostaglandin-replete dogsa
Glomerular filtr
mi/mm
ation rate Renal blood flow
mi/mm
Control Verapamil ADH PostcontrolControl Verapamil ADH Postcontrol
Infused 43.0 46.0 48.0 47.0 337 372 385 344
P NS NS NS NS NS NS
Noninfused 43.0 44.0 43.0 45.0 398 348 310 304
P NS NS NS NS NS NS
a Values are the means SEM (N = 8 dogs).
b P <0.05, compared with noninfused kidney in same experimental period.
P <0.005, compared with noninfused kidney in same experimental period.
Table 2. Effect of intrarenal verapamil on renal hemodynamics and solute and water excretion in prostaglandin-inhibited dogsa
Glomerular filtration rate Renal blood flow
mi/mm mi/mm
Control Verapamil ADH Postcontrol Control Verapamil ADH Postcontrol
Infused 44.0 43.0 48.0 43.0 380 435" 368' 346
P NS NS NS NS NS NS
Noninfused 37.0 37.0 44.0 45.0 423 367 292 312
P NS NS NS NS NS NS
a Values are the means SEM (N = 8 dogs).
"P <0.05, compared with noninfused kidney in same experimental period.C <0.01, compared with noninfused kidney in same experimental period.
d P <0.001, compared with noninfused kidney in same experimental period.
P <0.02, compared with noninfused kidney in same experimental period.














FIg. 1. Effect of 100 mU of vasopressin on urinary osmoiaiity in verapamii-infused kidneys (left panel) when compared with con-












Control Verapamil ADH Postcontrol Control Verapamil ADH Postcontrol Control Verapamil ADH Postcontrol
1.51 2.l8e 3.80 l.96c 3.16 37Qc —0.19 329b 85.0 117.0 270.0" 96.0
±0.32 ±0.42 ±0.70 ±0.20 ±0.32 ±0.33 ±0.36 ±0.55 ±11.3 ±14.5 ±22.7 ±12.1
<0.01 N5 <0.005 NS <0.001 <0.001 <0.05 <0.001 <0.001
1.26 1.19 1.56 0.96 2.79 2.35 —0.35 1.88 82.0 90.0 337.0 92.0
±0.26 ±0.27 ±0.32 ±0.12 ±0.30 ±0.25 ±0.22 ±0.25 ±7.0 ±11.8 ±45.5 ±7.2
NS NS NS NS <0.001 <0.001 NS <0.001 <0.001
Table 2. (continued)
Solute clearance Free water clearance Urinary osmolality
mi/rn in mi/mm rnOsrn/kg H20
Control Verapamil ADH Postcontrol Control Verapamil ADH Posteontrol Control Verapamil ADH Postcontrol
1.54 3.8' 4.52' 1.47 3.73 4.36" 2.89 79.0 104.0 280.0e 91.0
±0.25 ±0.5 ±0.39 ±0.27 ±0.47 ±0.56 ±0.20 ±0.46 ± 10.7 ±13.3 ±21.9 ±8.8
<0.001 N5 <0.001 NS <0.001 <0.001 NS <0.001
1.10 1.14 1.96 1.14 2.64 2.14 —1.05 1.75 80.0 87.0 650.0 115.0
±0.14 ±0.11 ±0.46 ±0.13 ±0.45 ±0.37 ±0.18 ±0.39 ±9.5 ±10.3 ±103.5 ±13.0
NS NS NS NS <0.001 <0.001 NS <0.001 <0.001
trol. The latter achieved a mean Uosm of 650 mOsml
kg H20, reflecting the enhanced response to vaso-
pressin in the PG-depleted state. In every animal,
the Uosm achieved in the contralateral control kid-
ney was higher than that of the ipsilateral infused
one, which achieved only a mean Uosm of 280
mOsm/kg H20 (P < 0.01). This latter response is
almost identical to that observed in infused kidneys
of animals not pretreated with PG inhibitors (280 vs.
270 mOsmlkg H20). Because a failure to suppress
PG synthesis in verapamil-treated kidneys could ex-
plain these results, PG excretion was measured in 7
of these dogs. Mean PG excretion was 4127 ± 832
pg/mm before indomethacin administration. This
drug suppressed PG excretion equally in verapamil-
treated kidneys (567 ± 67 pg/mm) and contralateral
control (598 ± 186 pg/mm).
As was the case in the animals not treated with
indomethacin, systemic pressure was not signifi-
cantly altered in these studies. In these PG-inhib-
ited animals, however, the verapamil-infused kid-
ney had a somewhat higher renal blood flow than its
contralateral control (Table 2). Because increases in
renal blood flow, particularly in the renal medul-
lary, could alter the response to vasopressin, 5 addi-
tional animals whose kidneys were vasodilated by
decreased renal perfusion pressure prior to the ex-
periments were studied. In these animals, vera-
pamil did not increase renal blood flow, and the in-
fused and contralateral kidneys had comparable
flows, 223 ± 40 and 201 ± 38 mllmin, respectively.
In spite of these comparable renal blood flows, the
response to 100 mU of vasopressin was very dif
ferent as the control uninfused kidney achieved a
maximal Uosm of 683 ± 142 mOsm/kg H20 and the
verapamil-infused kidney only 253 ± 25 mOsmlkg
H20 (P < 0.02).
(b) Effect of proadifen on the action of vasopres-
sin in PG-inhibited dogs (Table 3 and Fig. 2). To
ascertain that the profound effects exhibited by the
infusion of verapamil in the PG-depleted state was
not due to a nonspecific effect of this drug, we used
another chemically dissimilar agent that also blocks
slow channel calcium uptake. The intrarenal in-
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Table 3. Effect of intrarenal proadifen (SKF #525-A) on renal hemodynamics and solute
and water excretion in prostaglandin-inhibited dogsa
Glomerular flltration rate Renal blood flow
mi/mm mi/rn in
Control Proadifen ADH Postcontrol Control Proadifen ADH Postcontrol
Infused 33.0 38.0 35.0 32.0 155 222b 235b 162
P NS NS NS NS NS NS
Nonjnfused 36.0 36.0 31.0 27.0 162 169 150 140
P NS NS NS NS NS NS
a Values are the means SEM (N = 5 dogs).b P <0.05, compared with noninfused kidney in same experimental period.
P <0.01, compared with noninfused kidney in same experimental period.
P <0.02, compared with noninfused kidney in same experimental period.
P <0.005, compared with noninfused kidney in same experimental period.
Infused kidney Contralateral kidney
Fig. 2. Effect of 100 mU of vasopressin on urinary osmolality in proadifen-infused kidneys (left panel) when compared with con-
traiaterai uninfused controls (right panel) in prostagiandin-depieted dogs.
fusion of 0.375 mg/kg/mm caused no significant al-
terations in serum calcium or in systemic pressure.
As shown in Table 3, the infusion caused changes in
renal blood flow and solute clearance but no altera-
tion in the function of the contralateral kidney. As
was the case with verapamil, in each animal the
maximal Uosm achieved was greater in the control
than it was in the infused kidney (Fig. 2). Although
the former achieved a mean maximal Uosm of 590
mOsm/kg H20, the proadifen-infused kidney
reached only a mean Uosm of 278 mOsm/kg H20
(P <0.005).
(c) Effect of increased solute excretion on the re-
sponse to vasopressin in PG-inhibited dogs (Fig. 3).
Because both verapamil and proadifen caused an in-
crease in ipsilateral solute excretion (Tables 2 and
3), the possibility that the blunted response to vaso-
pressin observed in these kidneys as a consequence
of this effect was considered. In 5 animals, an in-
crement in solute excretion was achieved that was
comparable or even exceeded that observed in dogs
given the calcium uptake inhibitors. Thus, the mean
solute excretion in the mannitol-treated animals
was 5.32 0.56 mI/mm with a mean Uosm of 171
6.9 mOsm/kg H20. Despite the very high solute ex-
cretion (Fig. 3), the administration of 100 mU of
vasopressin increased maximal Uosm to a mean of
590 32 mOsmlkg H20, which is significantly
greater than observed in the verapamil-(P < 0.005)
or proadifen-infused kidneys (P < 0.02) and not dif-
ferent from that achieved by the contralateral unin-
fused kidneys in those experiments.
Discussion
The effect of an increase in extracellular fluid cal-
cium concentration to impair the renal concen-














































Fig. 3. Effect of increased solute excretion with mannitol on
the response to vasopressin in prosragiandin-depleted dogs.
Note that this response is comparable with that of the con-
tralateral kidneys and distinctly greater than that of the infused
kidneys in Figs. 1 and 2.
trating mechanism has been recognized for quite
some time [3, 4]. Only recently, however, has a role
of increased intracellular calcium concentration
been suggested to be a determinant of the action of
vasopressin [81. The recent availability of agents
that either promote or block the cellular uptake of
calcium has provided experimental tools to study
the effects of intracellular calcium concentration on
water transport. Although these agents have been
widely used in vitro, their in vivo effect on renal
water excretion has not been investigated. In the











cium uptake were used to investigate the in vivo ef-
fect of blockers of calcium membrane transport on
the hydroosmotic response to vasopressin.
In the initial group of studies, intrarenal vera-
pamil, a blocker of cellular membrane transport,
was found to produce blunting of the hydroosmotic
effect of submaximal doses of vasopressin. This ef-
fect was, however, very modest, and it should be
emphasized that in none of the animals did vera-
pamil prevent an antidiuresis. The small observed
difference could well be due to an in vivo effect of
verapamil to increase solute excretion rather than
to block cellular calcium uptake. Moreover, the
possibility existed that endogenous renal prosta-
glandins may inhibit calcium membrane transport
and thus obscure a more profound effect of calcium
transport inhibition on vasopressin-induced anti-
diuresis. If this were the situation, then the effect of
inhibitors of calcium blockade on vasopressin-in-
duced water transport would be more readily de-
tectable in PG-deplete animals.
To test this possibility, we examined the effect of
intrarenal verapamil on the hydroosmotic effect of
vasopressin in animals pretreated with indometha-
cm, a potent inhibitor of PG synthesis. In these
studies, a much greater inhibition of the antidiuretic
effect of vasopressin was observed in the vera-
pamil-infused kidneys (maximal Uosm, 650 vs. 280
mOsmlkg H20, P < 0.01). Because the Uosm in ye-
rapamil-treated kidneys of PG-deplete animals was
no higher than untreated kidneys in PG-replete ani-
mals (270 vs. 280 mOsmlkg H20), these results sug-
gest that verapamil totally abolished the known ef-
fect of PG inhibition to enhance the hydroosmotic
effect of vasopressin. This finding is compatible
with the interpretation that renal PG's normally
block calcium membrane transport, thus accounting
Control Vasopressin Postcontrol
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for their inhibition of the action of vasopressin. In
this regard, there is in vitro evidence that the action
of vasopressin is dependent on membrane calcium
transport because calcium ionophores enhance [7]
and verapamil [8] or a calcium-free medium [22] im-
pairs the action of vasopressin to enhance water
movement across the toad bladder. It therefore fol-
lowed that in the presence of diminished PG activity
it might be easier to demonstrate the effect of cal-
cium transport inhibition with verapamil to attenu-
ate the hydroosmotic response to vasopressin. Such
was clearly the case in the present study.
Because verapamil itself appears to be a mild in-
hibitor of PG synthesis [23], it is not likely that our
results can be explained by enhanced PG synthesis
on the infused kidney. In fact, our direct measure-
ments of PG excretion reveal that the observed hy-
droosmotic effect is not due to disparate PG excre-
tion in control and infused kidneys during indo-
methacin administration. It also seems clear from
the present results that neither verapamil-induced
increases in renal blood flow nor solute excretion
could explain the effect of diminution in vasopressin
response. Specifically, prior renal vasodilatation
that abolished the increase in renal blood flow with
verapamil did not alter the blocking effect of vera-
pamil on the antidiuretic effect of vasopressin.
Moreover, increases in solute excretion with man-
nitol to levels in excess of those observed with vera-
pamil did not similarly impair the antidiuretic effect
of vasopressin. Although these studies provide ade-
quate individual controls for each of these two vari-
ables, they do not combine them. It must be noted,
however, that the renal blood flow in the mannitol
studies was 305 45 mllmin during antidiuretic hor-
mone administration. This flow is not as high as that
of the verapamil-treated kidneys. It is, however, ac-
tually higher than proadifen-infused kidneys, pro-
viding a simultaneous combined control for these
experiments.
Last, the possibility was considered in the pres-
ent study that verapamil inhibited the action of
vasopressin, particularly in the PG-inhibited ani-
mals, by an action other than blockade of cellular
calcium uptake. To test this possibility, we exam-
ined the effect of another inhibitor of cell membrane
transport, proadifen, on the antidiuretic action of
vasopressin in PG-deplete animals. This cellular
blocker produced an inhibition of the hydroosmotic
effect of vasopressin that was comparable to that
observed with verapamil (590 vs. 278 mOsm!kg
1-120, P < 0.005).
The mechanism whereby PG's alter the hydro-
osmotic response to vasopressin has been a subject
of some controversy. There is considerable experi-
mental evidence from both in vivo [24] and in vitro
[25] studies to support the view that the effect in-
volves an alteration in the water permeability of the
collecting duct. But because both vasopressin and
PG [26] affect solute transport in the ascending limb
of Henle's loop, and both may well be involved in
the control of intrarenal blood flow distribution, it is
possible that their interaction also occurs by one or
both of these mechanisms. The above sited in vitro
data pointing to a role of cellular calcium on vaso-
pressin action [7, 8] would suggest that our in vivo
observations are mediated by a mechanism in-
volving alterations in the hydraulic permeability of
the collecting duct. The possibility, however, that
the calcium-blocking agents alter the PG-antidiuret-
ic hormone interaction by alternative pathways in-
volving either changes in solute transport in the as-
cending limb of Henle or intrarenal blood flow dis-
tribution that could alter interstitial tonicity cannot
be entirely excluded. These possibilities should be
subject of future investigation.
Summary. Two chemically dissimilar blockers of
calcium membrane transport were demonstrated to
block the in vivo antidiuretic effect of vasopressin.
This effect was most profound in the PG-deplete
state. Evidence was presented that the effect of
these inhibitors was unrelated to either the increase
in renal blood flow or solute excretion. The present
results thus are compatible with preliminary in vitro
data that suggest that intracellular calcium is an im-
portant determinant of the action of vasopressin.
Moreover, the ability of the two blockers to mimic a
PG-replete vasopressin response in a setting of PG
inhibition strongly suggests that PG's inhibit the in
vivo action of vasopressin primarily by impairing
calcium membrane transport.
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